Description: TISSIUM is creating the future of tissue reconstruction. Learn more about our novel solutions based on our proprietary platform of biomorphic programmable polymers.
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures:
To reconstruct damaged tissue and restore its natural function.
Our proprietary biomorphic programmable polymers enable tissue reconstruction and can be adapted for use in multiple clinical areas